EVKIF Stock Chart & Stats
$19.75
-$1.39(-6.92%)
At close: 4:00 PM EDT
$19.75
-$1.39(-6.92%)
Day’s Range― - ―
52-Week Range$14.49 - $23.93
Previous CloseN/A
Volume200.00
Average Volume (3M)329.00
Market Cap
$10.14B
Enterprise Value$11.54K
Total Cash (Recent Filing)$390.00M
Total Debt (Recent Filing)$4.46B
Price to Earnings (P/E)71.7
Beta0.50
Next Earnings
Nov 03, 2026EPS Estimate
0.56Next Dividend Ex-DateN/A
Dividend Yield4.82%
Share Statistics
EPS (TTM)0.26
Shares Outstanding466,000,000
10 Day Avg. Volume50
30 Day Avg. Volume329
Financial Highlights & Ratios
PEG Ratio1.25
Price to Book (P/B)0.77
Price to Sales (P/S)0.44
P/FCF Ratio8.96
Enterprise Value/Market Cap<0.01
Enterprise Value/Revenue<0.01
Enterprise Value/Gross Profit<0.01
Enterprise Value/Ebitda<0.01
Forecast
1Y Price Target
$21.46Price Target Upside8.66% Upside
Rating ConsensusHold
Number of Analyst Covering8
EPS Forecast (FY)1.91
Revenue Forecast (FY)$16.90B
Bulls Say, Bears Say
Bulls Say
Strong Cash GenerationConsistent operating cash flow and a TTM free cash flow rebound (~+38%) provide durable internal funding for capex, dividends and R&D. Reliable cash conversion cushions the business through earnings volatility and supports strategic investments without heavy external financing.
Manageable Leverage / Solid Balance SheetModerate debt-to-equity (~0.57) and a sizable equity base give structural financial flexibility. This reduces refinancing and solvency risk over cycles, enabling the company to fund working capital or pursue targeted investments and M&A without undermining credit stability.
Specialty, Value-added Business ModelA diversified specialty-chemicals portfolio focused on application-specific solutions creates higher customer stickiness and pricing leverage versus commodity peers. Technical services and formulation know-how support repeat sales, insulating revenue from pure price competition over the medium term.
Bears Say
Thin And Volatile ProfitabilityVery slim net margins (TTM <1%) and prior net losses mean limited buffer against input-cost shocks. Thin bottom-line profitability constrains retained earnings, limits flexibility for sustained dividend increases, and makes long-term capital allocation more sensitive to cyclical swings.
Low Returns On EquityA TTM ROE near 1.5% signals weak capital efficiency and modest shareholder value creation. Persistently low ROE reduces the company's ability to convert invested capital into attractive returns, making it harder to justify growth investments and maintain high returns over the medium term.
Weak / Inconsistent Revenue TrendsRevenue has shown only modest TTM growth after multiple flat or down years, reflecting end-market cyclicality. Inconsistent top-line trends hinder long-term margin expansion and forecasting, making investment planning and sustained improvement in profitability more challenging.
Evonik News
EVKIF FAQ
What was Evonik’s price range in the past 12 months?
Evonik lowest stock price was $14.49 and its highest was $23.93 in the past 12 months.
What is Evonik’s market cap?
Evonik’s market cap is $10.14B.
When is Evonik’s upcoming earnings report date?
Evonik’s upcoming earnings report date is Nov 03, 2026 which is in 67 days.
How were Evonik’s earnings last quarter?
Evonik released its earnings results on Aug 04, 2026. The company reported $0.75 earnings per share for the quarter, beating the consensus estimate of $0.638 by $0.112.
Is Evonik overvalued?
According to Wall Street analysts Evonik’s price is currently Undervalued.
Does Evonik pay dividends?
Evonik pays a Annually dividend of $1.153 which represents an annual dividend yield of 4.82%. See more information on Evonik dividends here
What is Evonik’s EPS estimate?
Evonik’s EPS estimate is 0.56.
How many shares outstanding does Evonik have?
Evonik has 466,000,000 shares outstanding.
What happened to Evonik’s price movement after its last earnings report?
Evonik reported an EPS of $0.75 in its last earnings report, beating expectations of $0.638. Following the earnings report the stock price went same 0%.
Which hedge fund is a major shareholder of Evonik?
Currently, no hedge funds are holding shares in EVKIF
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Evonik Stock Smart Score
Neutral
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Hold
Average Price Target:
$21.46 (8.66% Upside)
$21.46 (8.66% Upside)
Blogger Sentiment
Bullish
EVKIF Sentiment 100%
Sector Average ―
Sector Average ―
Insider Transactions
Bought Shares
Worth $116.6K over
the Last 3 Months
the Last 3 Months
Technicals
SMA
Negative
20 days / 200 days
Momentum
-19.74%
12-Months-Change
Fundamentals
Return on Equity
4.82%
Trailing 12-Months
Asset Growth
-2.30%
Trailing 12-Months
Company Description
Evonik
Evonik Industries AG operates primarily in the specialized chemicals market. Its business activities are structured across five principal divisions: Specialty Additives, Nutrition & Care, Smart Materials, Performance Materials, and Technology & Infrastructure. The Specialty Additives segment is responsible for delivering essential ingredients such as polyurethane additives, modified silicones, isophorones, epoxy hardeners, oil modifiers, fumed silicas, matting agents, TAA compounds, and acetylenic diol-based surfactants, which find use in consumer products and various industrial applications. In the Nutrition & Care division, Evonik provides compounds like amphoteric surfactants, ceramides, phytosphingosines, oleochemicals, quaternary derivatives, amino acids and their derivatives, synthetic products, pharmaceutical-grade polymers, and DL-methionine. These are crucial for consumer goods, animal nutrition, and healthcare industries. The Smart Materials segment manufactures advanced substances including hydrogen peroxide, peracetic acid, various activated nickel and precious metal catalysts (for powder, oil, and fat hydrogenation), amorphous polyalphaolefins, polybutadienes, polyester resins, thermoplastic and reactive methacrylate resins, PEEK, polyamide 12, organosilanes, chlorosilanes, and different types of silicas (fumed and precipitated). These serve a broad spectrum of industries including automotive, paints, coatings, adhesives, and construction. Through its Performance Materials segment, the company produces polymer materials and intermediate chemicals, including butene-1, DINP, isononanol, cyanuric chloride, alkoxides, and superabsorbents, specifically for the rubber, plastics, and automotive sectors. Lastly, the Technology & Infrastructure segment provides crucial internal services, encompassing site management, utilities and waste disposal, technical expertise, process technology, engineering, and logistics. Evonik maintains a significant international presence, with operations spanning across the Asia-Pacific region, Europe, the Middle East, Africa, Central and South America, and North America. Founded in 1873, the firm's main offices are located in Essen, Germany, and it functions as a subsidiary of RAG-Stiftung.
EVKIF Stock 12 Month Forecast
Average Price Target
$21.46
▲(8.66% Upside)
Ownership Overview
― Insiders
7.81% Mutual Funds
<0.01% Other Institutional Investors
81.74% Public Companies and
Individual Investors